Impaired mesenchymal stem cell differentiation and osteoclastogenesis in mice deficient for Igf2-P2 transcripts

Citations Over TimeTop 23% of 2010 papers

Abstract

During embryonic development, Igf2 gene transcription is highly regulated through the use of several promoters whose specific roles are not defined. Here, we show that loss-of-function of one of these promoters, Igf2-P2, results in growth defects that are temporally and quantitatively different from those seen in Igf2-null mutants. In particular, Igf2-P2 mutants exhibit skeletal abnormalities characterized by thin and short bones with reduced mineralization and medullar cavity and with altered bone remodeling. These abnormalities are associated with decreased numbers of embryonic mesenchymal chondroprogenitors, adult mesenchymal stem cells and osteoprogenitors. Differentiation of osteoprogenitors into osteoblasts is impaired in the Igf2-P2 mutant mice in a cell-autonomous manner, and osteopontin is a target of the IGF2 signaling pathway during this differentiation. Igf2-P2 mutant mice also display impaired formation of giant osteoclasts owing to a defective micro-environment. These results support a model wherein transcriptional activity of the Igf2-P2 promoter regulates the fate of mesenchymal progenitors during bone development and remodeling in the adult, and regulates osteogenesis in a cell-autonomous and non-autonomous manner.

Related Papers

• → Tissue specificity and developmental expression of rat osteopontin(1987)316 cited
• → Correliation Between Osteopontin Protein Expression and Histological Grade of Astrocytomas(2008)26 cited
• → Studies on the role of osteopontin-1 in endometrial cancer cell lines(2013)9 cited
• → Recognition of Osteopontin by Rat Bone Marrow Derived Osteoblastic Primary Cells(1997)11 cited
• Expression of osteopontin in colon cancer tissue and detection of osteopontin in serum(2007)